Filing Details
- Accession Number:
- 0001179110-15-007529
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 16:45:26
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 16:45:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1065087 | Albany Molecular Research Inc | AMRI | Services-Commercial Physical & Biological Research (8731) | 141742717 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1449207 | R Steven Hagen | 26 Corporate Circle Albany NY 12203 | Svp Manufacturing & Pharmaceut | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-08 | 7,000 | $8.90 | 38,200 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-05-08 | 7,000 | $19.35 | 31,200 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-05-08 | 7,500 | $11.21 | 38,700 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-05-08 | 7,500 | $19.20 | 31,200 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to Purchase Common Stock | Acquisiton | 2015-05-08 | 7,000 | $0.00 | 7,000 | $8.90 |
Common Stock | Option to Purchase Common Stock | Acquisiton | 2015-05-08 | 7,500 | $0.00 | 7,500 | $11.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-03-08 | No | 4 | M | Direct | |
0 | 2018-03-17 | No | 4 | M | Direct |
Footnotes
- Option grant was fully exercisable March 8, 2015.
- Option grant was fully exercisable March 17, 2013.